3759.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (2 5月 2024 @ 17:08):

Stats
本日の出来高	1.57M
平均出来高	5.46M
時価総額	34.70B
EPS	HKD0.371 ( 2023-06-30 )
Last Dividend	HKD0.329 ( 2023-07-18 )
Next Dividend	HKD0 ( N/A )
P/E	11.64
ATR14	HKD0.0280 (0.27%)

ボリューム相関

長: 0.03 (neutral)

短: 0.53 (weak)

Signal:(56.233) Neutral

Pharmaron Beijing Co., 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Pharmaron Beijing Co., 相関 - 通貨/商品

0.60
( weak )

0.43
( neutral )

0.00
( neutral )

0.48
( neutral )

0.65
( moderate )

-0.37
( neutral )

Pharmaron Beijing Co., 財務諸表

Annual	2023
収益:	HKD11.54B
総利益:	HKD4.12B (35.75 %)
EPS:	HKD0.900

FY	2023
収益:	HKD11.54B
総利益:	HKD4.12B (35.75 %)
EPS:	HKD0.900

FY	2022
収益:	HKD10.27B
総利益:	HKD3.77B (36.71 %)
EPS:	HKD1.160

FY	2021
収益:	HKD7.44B
総利益:	HKD2.68B (35.99 %)
EPS:	HKD2.10

Financial Reports:

No articles found.

Pharmaron Beijing Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.329 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Pharmaron Beijing Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.50 - Stable (10.05%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.109	2020-06-01
Last Dividend	HKD0.329	2023-07-18
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	HKD1.208	--
Avg. Dividend % Per Year	0.00%	--
Score	3.06	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.50
Div. Directional Score	8.41	--

Next Divdend (Est)
(2024-07-19)

HKD0.220 Estimate 3.08 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.06

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2368.HK	Ex Dividend Knight	2023-08-25	Semi-Annually	0.00%
1357.HK	Ex Dividend Junior	2023-06-05	Insufficient data to determine frequency	0.00%
0398.HK	Ex Dividend Knight	2023-09-29	Semi-Annually	0.00%
6690.HK	Ex Dividend Knight	2023-07-24	Annually	0.00%
1905.HK	Ex Dividend Knight	2023-10-20	Semi-Annually	0.00%
0934.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
0057.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
2885.HK	Ex Dividend Junior	2023-06-15	Annually	0.00%
1501.HK	Ex Dividend Junior	2023-05-24	Annually	0.00%
0552.HK	Ex Dividend Junior	2023-07-03	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.129	1.500	7.42	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0588	1.200	8.04	9.65	[0 - 0.3]
returnOnEquityTTM	0.122	1.500	9.76	10.00	[0.1 - 1]
payoutRatioTTM	0.321	-1.000	6.79	-6.79	[0 - 1]
currentRatioTTM	2.52	0.800	2.42	1.938	[1 - 3]
quickRatioTTM	1.941	0.800	3.29	2.63	[0.8 - 2.5]
cashRatioTTM	1.234	1.500	4.26	6.39	[0.2 - 2]
debtRatioTTM	0.327	-1.500	4.55	-6.83	[0 - 0.6]
interestCoverageTTM	12.59	1.000	6.45	6.45	[3 - 30]
operatingCashFlowPerShareTTM	1.672	2.00	9.44	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.220	2.00	9.89	10.00	[0 - 20]
debtEquityRatioTTM	0.650	-1.500	7.40	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.350	1.000	7.50	7.50	[0.2 - 0.8]
operatingProfitMarginTTM	0.148	1.000	9.03	9.03	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.360	1.000	9.11	9.11	[0.2 - 2]
assetTurnoverTTM	0.455	0.800	-0.300	-0.240	[0.5 - 2]
Total Score				11.32

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.04	1.000	8.99	0	[1 - 100]
returnOnEquityTTM	0.122	2.50	9.84	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.220	2.00	9.93	10.00	[0 - 30]
dividendYielPercentageTTM	3.56	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.672	2.00	9.44	10.00	[0 - 30]
payoutRatioTTM	0.321	1.500	6.79	-6.79	[0 - 1]
pegRatioTTM	-0.714	1.500	-8.09	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.259	1.000	6.04	0	[0.1 - 0.5]
Total Score				5.50

Pharmaron Beijing Co.,

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and Others. It offers laboratory chemistry solutions, including medicinal, synthetic, and analytical and purification chemistry, as well as computer-aided drug design services; bioscience services comprising in vitro and in vivo drug metabolism and pharmacokinetics/absorption, distribution, metabolism, and excretion solutions; and in vitro biology and in vivo pharmacology, safety assessment, and the U.S. laboratory services. The company also provides process development and manufacturing, material science/pre-formulation, formulation development and manufacturing, and analytical development services; and radiolabelled science services and early stage clinical trial services, as well as clinical research and site management services. It also provides business development; and contract research, development, and manufacturing services for pharmaceutical products. The company was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.